Four-decade mystery solved as PKCβ structure reveals new drug target

After nearly four decades of research, Mayo Clinic scientists have revealed the molecular structure of protein kinase C beta (PKCβ), a key protein linked to cancer and neurological diseases. The findings, published in Nature Communications, provide the first detailed view of how the protein works and how the breast cancer drug endoxifen can target it.